Trial
NCT04374279
Trial to Promote Recovery From COVID-19 With Endocrine Therapy
Phase IIWITHDRAWNOTHER/UNKNOWNConfidence: LOW
Sponsor
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Collaborators
—
Condition
COVID-19
Intervention
Bicalutamide 150 Mg Oral Tablet
Why stopped
Limited resources.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2021-03-05